Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
An amfAR grant will help find out. Plus, the AIDS research group also awards three new Mathilde Krim HIV fellowships.
The latest Campbell Foundation research grant will help a UCLA scientist study HIV’s ability to mutate during CAR-T gene therapy.
The first two people treated with the “living drug” remained cancer-free for a decade and can be considered cured.
With $600,000 in amfAR HIV grants, research teams explore CAR-T cells, bFAbs and CRISPR/Cas9 gene editing to eradicate the reservoir.
This strategy entails genetically modifying a person’s stem cells to give rise to T cells that target and destroy cells infected with HIV.
Research shows that CAR-T cells could one day help cure HIV in humans.
CAR-T cells, which have recently made waves in the cancer field, may one day be the basis of a cure for HIV in humans.
Cancer and HIV are invaders that the immune system fails to detect, and the similarities don’t end there.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.